| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Coeur d'Alene Mines Corporation
| NYSE
|
CDE
|
13.66
|
|
+0.15
(1.11%)
| 1.39B
|
|
|
Coeur Mining, Inc., formerly Coeur d'Alene Mines Corporation, is a silver
producer with gold production and has assets located in the United States,
Mexico, ...
| |
| |
|
|
Dominion Resources, Inc.
| NYSE
|
D
|
58.08
|
|
-1.18
(-1.99%)
| 33.55B
|
|
|
Dominion Resources, Inc. (Dominion) is a producer and transporter of energy. The
Company is a provider of electricity, natural gas and related services to ...
|
Executive:
Paul D. Koonce
| |
|
|
Apple Inc.
| NASDAQ
|
AAPL
|
444.07
|
|
+2.71
(0.61%)
| 417.46B
|
|
|
Apple Inc. (Apple) designs, manufactures and markets mobile communication and
media devices, personal computers, and portable digital music players, ...
|
Executive:
Arthur D. Levinson Ph.D.
| |
|
|
Amarin Corporation plc (ADR)
| NASDAQ
|
AMRN
|
6.85
|
|
-0.04
(-0.54%)
| 1.03B
|
|
|
Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with
expertise in lipid science focused on the treatment of cardiovascular ...
| |
| |
|
|
Enbridge Inc
| TSE
|
ENB-D
|
25.88
|
|
0.00
(0.00%)
| 39.99B
|
|
|
Enbridge Inc. (Enbridge) transports and distributes energy across North America.
As a transporter of energy, Enbridge operates, in Canada and the United ...
| |
| |
|
|
Pfizer Inc.
| NYSE
|
PFE
|
29.02
|
|
-0.28
(-0.96%)
| 205.85B
|
|
|
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The
Company manages its operations through five segments: Primary Care; ...
|
Executive:
Frances D Fergusson Ph.D.
| |
|
|
Merck & Co., Inc.
| NYSE
|
MRK
|
46.63
|
|
-0.08
(-0.17%)
| 140.80B
|
|
|
Merck & Co., Inc. (Merck) is a global health care company that delivers health
solutions through its prescription medicines, vaccines, biologic therapies, ...
|
Executive:
Thomas R. Cech Ph.D.
| |
|
|
WASH MUTUAL INC D/S K
| OTCMKTS
|
WAMKQ
|
|
|
|
|
|
|
|
|
|
Sequenom, Inc.
| NASDAQ
|
SQNM
|
3.98
|
|
+0.07
(1.79%)
| 458.29M
|
|
|
Manufactures DNA detection and sequencing equipment. The Company's two business
units combine to utilize their MassARRAY system, SNP assay portfolio, ...
|
Executive:
Carolyn D. Beaver
| |
|
|
Dundee Real Estate Investment Trust
| TSE
|
D.UN
|
35.19
|
|
-0.37
(-1.04%)
| 3.67B
|
|
|
Dundee Real Estate Investment Trust (the Trust) is an open-ended investment
trust. The Trust's portfolio comprises office and industrial properties located
...
| |
| |
|
|
Barclays ETN+ Short D linked to the S&P 500 Total Return Index
| NYSE
|
BXDD
|
9.99
|
|
|
|
|
|
|
|
|
Inovio Pharmaceuticals Inc
| NYSEMKT
|
INO
|
0.686
|
|
-0.014
(-2.00%)
| 123.44M
|
|
|
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation
of vaccines, called synthetic vaccines, focused on cancers and infectious ...
|
Executive:
Adel AF Mahmoud MD, Ph.D.
| |
|
|
Exelixis, Inc.
| NASDAQ
|
EXEL
|
4.63
|
|
+0.05
(1.09%)
| 851.00M
|
|
|
Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small
molecule therapies for the treatment of cancer. The Company is focusing its ...
| |
| |
|
|
Magnum D'Or Resources Inc
| OTCMKTS
|
MDOR
|
|
|
|
|
|
|
Magnum d'Or Resources, Inc. is engaged in the business of providing modified
sources of recycled rubber products, reconstituted rubber derivatives, ...
| |
| |
|
|
MediciNova, Inc.
| NASDAQ
|
MNOV
|
3.06
|
|
-0.12
(-3.77%)
| 55.83M
|
|
|
MediciNova, Inc. is a development-stage biopharmaceutical company focused on
acquiring and developing small molecule therapeutics for the treatment of ...
|
Executive:
David D. O'Toole CPA
| |
|
|
Barclays PLC American Depositary Shares (Each representing Non-Cumulative Callable Dollar Preference Shares, Series 5
| NYSE
|
BCS-D
|
25.74
|
|
-0.10
(-0.39%)
| 2.58B
|
|
|
|
|
|
Regeneron Pharmaceuticals Inc
| NASDAQ
|
REGN
|
254.90
|
|
-7.52
(-2.87%)
| 24.97B
|
|
|
Regeneron Pharmaceuticals, Inc. (Regeneron) is an integrated biopharmaceutical
company, which discovers, invents, develops, manufactures, and commercializes
...
| |
| |
|
|
Intel Corporation
| NASDAQ
|
INTC
|
24.05
|
|
-0.02
(-0.08%)
| 118.95B
|
|
|
Intel Corporation designs and manufactures integrated digital technology
platforms. A platform consists of a microprocessor and chipset.
|
Executive:
Andy D. Bryant
| |
|
|
Bank of America Corporation Depositary Shares Rpstg 1/1000th Interest in Sh of Non Cum Pfd Stk Ser D
| NYSE
|
BAC-D
|
25.65
|
|
-0.06
(-0.23%)
| 679.62M
|
|
|
|
|
|
Pharmacyclics, Inc.
| NASDAQ
|
PCYC
|
81.74
|
|
-0.61
(-0.74%)
| 5.95B
|
|
|
Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on
developing and commercializing small-molecule drugs for the treatment of cancer
...
| |
| |
|
|
Show all 9162 companies »
|
|
| Mutual Fund
| Symbol
| Nav
| Nav change
|
|
|
PIMCO All Asset Fund Class D
|
PASDX
| 12.79
|
-0.04
(-0.31%)
|
|
|
The investment seeks maximum real return, consistent with preservation of real
capital and prudent investment management. The fund normally invests all of ...
|
Executive:
Robert D. Arnott.
| |
|
|
PIMCO RealEstateRealReturn Strategy Fund Class D
|
PETDX
| 5.16
|
-0.20
(-3.73%)
|
|
|
The investment seeks maximum real return consistent with prudent investment
management. The fund seeks to achieve its investment objective by investing in
...
| |
| |
|
|
AllianzGI Mid-Cap Fund Class D
|
DMCNX
| 3.30
|
-0.04
(-1.20%)
|
|
|
The investment seeks long-term capital appreciation. The fund normally invests
at least 80% of its net assets in common stocks and other equity securities ...
| |
| |
|
|
PIMCO Total Return Fund Class D
|
PTTDX
| 11.19
|
-0.05
(-0.44%)
|
|
|
The investment seeks maximum total return, consistent with preservation of
capital and prudent investment management. The fund normally invests at least 65
% ...
| |
| |
|
|
PIMCO GNMA Fund Class D
|
PGNDX
| 11.40
|
-0.04
(-0.35%)
|
|
|
The investment seeks maximum total return, consistent with preservation of
capital and prudent investment management. The fund normally invests at least 80
% ...
| |
| |
|
|
PIMCO Income Fund Class D
|
PONDX
| 12.79
|
-0.01
(-0.08%)
|
|
|
The investment seeks to maximize current income; long-term capital appreciation
is a secondary objective. The fund invests at least 65% of its total assets ...
| |
| |
|
|
PIMCO All Asset All Authority Fund Class D
|
PAUDX
| 10.93
|
-0.04
(-0.36%)
|
|
|
The investment seeks maximum real return, consistent with preservation of real
capital and prudent investment management. The fund normally invests all of ...
|
Executive:
Robert D. Arnott.
| |
|
|
Janus Balanced Fund Class D
|
JANBX
| 28.85
|
-0.13
(-0.45%)
|
|
|
The investment seeks long-term capital growth, consistent with preservation of
capital and balanced by current income. The fund pursues its investment ...
| |
| |
|
|
Janus Fund Class D
|
JANDX
| 35.79
|
-0.38
(-1.05%)
|
|
|
The investment seeks long-term growth of capital. The fund pursues its
investment objective by investing primarily in common stocks selected for their
...
| |
| |
|
|
Janus Contrarian Fund Class D
|
JACNX
| 17.69
|
-0.14
(-0.79%)
|
|
|
The investment seeks long-term growth of capital. The fund pursues its
investment objective by investing, under normal circumstances, at least 80% of
its ...
| |
| |
|
|
PIMCO CommodityRealReturn Strategy Fund Class D
|
PCRDX
| 6.15
|
-0.04
(-0.65%)
|
|
|
The investment seeks maximum real return, consistent with prudent investment
management. The fund normally invests in commodity-linked derivative ...
| |
| |
|
|
PIMCO Real Return Fund Class D
|
PRRDX
| 11.96
|
-0.11
(-0.91%)
|
|
|
The investment seeks maximum real return, consistent with preservation of
capital and prudent investment management. The fund normally invests at least 80
% ...
| |
| |
|
|
PIMCO Fundamental IndexPLUS AR Fund Class D
|
PIXDX
| 6.78
|
-0.08
(-1.17%)
|
|
|
The investment seeks total return which exceeds that of its benchmark. The fund
seeks to exceed the total return of the S&P 500 Index (the "S&P 500") by ...
| |
| |
|
|
Janus Twenty Fund Class D
|
JNTFX
| 69.45
|
-0.57
(-0.81%)
|
|
|
The investment seeks long-term growth of capital. The fund pursues its
investment objective by normally investing primarily in a core group of 20-30
common ...
| |
| |
|
|
PIMCO Investment Grade Corporate Bond Fund Class D
|
PBDDX
| 11.20
|
-0.05
(-0.44%)
|
|
|
The investment seeks maximum total return, consistent with preservation of
capital and prudent investment management. The fund normally invests at least 80
% ...
| |
| |
|
|
Janus Triton Fund Class D
|
JANIX
| 20.57
|
-0.31
(-1.48%)
|
|
|
The investment seeks long-term growth of capital. The fund pursues its
investment objective by investing primarily in common stocks selected for their
...
|
Executive:
Jonathan D. Coleman.
| |
|
|
PIMCO Emerging Markets Bond Fund Class D
|
PEMDX
| 12.28
|
0.00
(0.00%)
|
|
|
The investment seeks maximum total return, consistent with preservation of
capital and prudent investment management. The fund normally invests at least 80
% ...
| |
| |
|
|
Janus Global Select Fund Class D
|
JANRX
| 11.38
|
-0.10
(-0.87%)
|
|
|
The investment seeks long-term growth of capital. The fund pursues its
investment objective by normally investing primarily in a core group of 40-70
...
| |
| |
|
|
PIMCO Low Duration Fund Class D
|
PLDDX
| 10.47
|
-0.02
(-0.19%)
|
|
|
The investment seeks maximum total return, consistent with preservation of
capital and prudent investment management. The fund invests at least 65% of its
...
| |
| |
|
|
PIMCO Foreign Bond (Unhedged) Fund Class D
|
PFBDX
| 9.91
|
-0.05
(-0.50%)
|
|
|
The investment seeks maximum total return, consistent with preservation of
capital and prudent investment management. The fund invests at least 80% of its
...
| |
| |
|
|
Show all 3321 funds »
|
